MedTech Featured Stories

Bristol subpoenaed over foreign sales practices

4/26/2012

U.S. drugmaker Bristol-Myers Squibb Co said on Thursday that it received a subpoena from securities regulators regarding its sales and marketing practices in various foreign countries.

Bristol-Myers, in a filing, said it received the subpoena from the U.S. Securities and Exchange Commission (SEC) last month in connection with an investigation under the Foreign Corrupt Practices Act (FCPA).
 

Reuters



Return to Previous Page

Today Is:
Wednesday, September 17, 2014


September Events

<< >>
SMTWTFS
123456
78910111213
14151617181920
21222324252627
282930